Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 5
Volume 11 (2024) | Issue 4
Head and neck cancer is the sixth most prevalent cancer, constituting 3% of all localizations. In 48% of instances, oral cancers are squamous cell carcinomas. Epidermal growth factor receptor (EGFR) is an ErbB family tyrosine kinase receptor expressed in solid tumours, including head and neck squamous cell carcinoma (HNSCC). HNSCCs have various clinicopathological characteristics and a dismal prognosis.